Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02DOX
|
|||
Former ID |
DNC011328
|
|||
Drug Name |
NSC-677939
|
|||
Synonyms |
NSC-677939; NSC677939; CHEMBL1287982; AC1L8RA1; Diindolo[2,2-h]quinolizine; CTK8D1116; ZINC1647054; BDBM50332189; {Diindolo[2,3-a:3,2-h]quinolizine}; NCI60_027847; 14H-Diindolo[2,3-a:3,2-h]quinolizine; 14h-diindolo[2,3-a:3',2'-h]quinolizine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H13N3
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C3=C(N2)C4=C5C(=C6C=CC=CC6=N5)C=CN4C=C3
|
|||
InChI |
1S/C21H13N3/c1-3-7-17-13(5-1)15-9-11-24-12-10-16-14-6-2-4-8-18(14)23-20(16)21(24)19(15)22-17/h1-12,22H
|
|||
InChIKey |
MNJDUMFRXPRNJB-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Quinone reductase 2 (NQO2) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.